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One titrimetric and two spectrophotometric methods which
are simple, sensitive and rapid are described for the assay
of salbutamol sulphate (SBS) in bulk drug and in tablet
dosage forms using N-bromosuccinimide (NBS) and two
dyes, rhodamine-B and methylene blue, as reagents. In ti-
trimetry, aqueous solution of salbutamol sulphate is treat-
ed with a measured excess of NBS in acetic acid medium
and after the oxidation of SBS is complete, the unreacted
oxidant is determined iodometrically. Spectrophotometric
methods entail addition of a known excess of NBS in acid
medium followed by the determination of residual oxidant
by reacting with a fixed amount of either rhodamine B and
measuring the absorbance at 555 nm (method A) or methy-
lene blue and measuring the absorbance at 665 nm (me-
thod B). In all methods, the amount of NBS reacting corre-
sponds to the amount of SBS content. Titrimetric method is
applicable over 1.74 x 10–4 – 8.68 ´ 10–4 mol L–1 range and
the reaction stoichiometry is found to be 1:6 (SBS:NBS). In
spectrophotometric methods, the absorbance is found to
increase linearly with the concentration of SBS, which is
corroborated by the correlation of coefficients of 0.9993 and
0.9988 for method A and method B, respectively. The sys-
tems obey Beer’s law for 0.25–1.75 mg mL–1 (method A)
and 0.5–5.0 mg mL–1 (method B). The calculated apparent
molar absorptivity values were found to be 2.10 x 105 and
6.16 x 104 L mol–1 cm–1, for method A and method B, re-
spectively. The limits of detection and quantification are
also reported for both spectrophotometric methods. Intra-
day and inter-day precision and accuracy for the develo-
ped methods were evaluated. The methods were success-
fully applied to the assay of SBS in tablet and capsule for-
mulations and the results were statistically compared with
those of a reference method. No interference was ob-
served from common tablet adjuvants. The accuracy and
reliability of the methods were further ascertained by re-
covery experiments via the standard-addition technique.
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Salbutamol sulphate (SBS) whose structure is given in Fig. 1 is a selective b-2-ago-
nist antiasthmatic. Its primary action is to stimulate adenyl cyclase which catalyzes the
formation of cyclic adenosin monophosphate. The drug is official in European Pharmaco-
poeia (1), which describes a potentiometric titration in non-aqueous medium, British Phar-
macoeia (2) and Indian Pharmacopoeia (3). Some different methods of analysis have been
reported for the determination of SBS, including HPLC (4–6) and UV-spectrophotometry
(7, 8), but most of them require extensive sample preparation prior to the measurement
step, some are less sensitive and some other are relatively complicated in terms of assay
procedure or equipment required for analysis.
SBS in pharmaceuticals has been assayed by visible spectrophotometric methods ba-
sed on reactions such as redox (9, 10), reduction followed by chelation (11), oxidative co-
upling (12, 13), diazotization and coupling (14, 15), nitrosation (16), nitration (17), nitra-
tion followed by Meisenheiner complex formation (18) and charge-transfer complex for-
mation (19). However, many of these procedures suffer from some disadvantage, such as
poor sensitivity, heating or extraction step, critical working conditions or the use of or-
ganic solvents, and are hence unsatisfactory for routine analysis. The only visual titrime-
tric method (20) reported employs NBS as the oxidimetric titrant in the presence of po-
tassium bromide and using methyl red as indicator. However, the method is applicable
over a macro scale. Recently, Issa et al. (21) have reported a conductometric titration met-
hod using phosphotungstic and phosphomolybdic acids as titrants. Even these proce-
dures are time consuming and less sensitive.
This paper describes three assay methods for SBS in tablets and capsules. The meth-
ods employ N-bromosuccinimide as an oxidizing agent, rhodamine-B and methylene blue
dyes as reagents. The proposed methods have the advantages of being rapid and simple
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Fig. 1. Tentative reaction pathway.
and are free from interferences from common tablet and capsule excipients. The results
obtained were closely comparable to those of a reported method, and recovery tests we-
re also found to be satisfactory.
EXPERIMENTAL
Apparatus
A Systronics Model 106 digital spectrophotometer (Systronics India Ltd., India) pro-
vided with 1-cm matched quartz cells was used for absorbance measurements.
Reagents and standard solutions. – All chemicals used were of analytical reagent grade
and solutions were made in distilled water.
NBS solution (0.01 mol L–1) was prepared by dissolving N-bromosuccinimide (SRL
Research Chemicals, India) in water with the aid of heat and standardized (22). The so-
lution was kept in an amber coloured bottle stored in a refrigerator and used for titri-
metry. It was diluted with water to get 70 and 150 mg mL–1 NBS for use in spectrophoto-
metric methods.
Sodium thiosulphate solution (0.01 mol L–1, Sisco Chem. Industries, India) was pre-
pared in water and standardized. Potassium iodide (10%) and starch (1%) were prepa-
red in the usual way. A stock solution of rhodamine B (500 mg mL–1) was prepared by
dissolving the dye (s. d. Fine Chem. Ltd., India, dye content 80%) in water and filtered
using glass wool. The dye solution was diluted to 50 mg mL–1 for method A. 400 mg mL–1
methylene blue was prepared by dissolving the dye (s. d. Fine Chem., dye content 70%)
in water and filtered. It was diluted to 40 mg mL–1 with water and used in method B.
Pharmaceutical grade SBS (certified to be 99.7% pure) was procured from Cipla In-
dia Ltd. (India) and was used as received. A stock standard solution equivalent to 1 mg
mL–1 SBS was prepared in water and was used in titrimetric work. This solution was ap-
propriately diluted with water to yield working concentrations of 5 and 10 mg mL–1 for
use in method A and method B, respectively.
Assay procedures
Titrimetry. – A 10-mL aliquot of pure drug solution containing 1.0–5.0 mg of SBS
was accurately measured and transferred into a 100-mL titration flask. The solution was
acidified by adding 5 mL of 5 mol L–1 acetic acid followed by the addition of 10 mL of
0.01 mol L–1 NBS. The content was mixed well and the flask was kept aside for 15 min
under occasional swirling. Then, 5 mL of 10% potassium iodide was added to the flask
and the liberated iodine was titrated with 0.01 mol L–1 sodium thiosulphate to a starch
end point. A blank titration was run under the same conditions.
Spectrophotometric method A. – Aliquots of pure SBS solution (0.5 to 3.5 mL, 5 mg
mL–1) were transferred into a series of 10-mL calibrated flask and the total volume was
adjusted to 4 mL with water. To each flask, 1 mL of 1 mol L–1 hydrochloric acid, was
added, followed by 1 mL of NBS solution (70 mg mL–1). The contents were mixed and
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the flasks were set aside for 10 min under occasional shaking. Finally, 1 mL of 50 mg
mL–1 rhodamine B solution was added to each flask, diluted to the mark with water and
the absorbance of solution was measured at 555 nm against a reagent blank after 10 min.
Spectrophotometric method B. – Varying aliquots (0.5–5.0 mL) of standard 10 mg mL–1 SBS
solution were accurately measured and delivered into a series of 10-mL calibrated flasks,
and the total volume was made up to 5.0 mL with water. To each flask, 1 mL each of 5
mol L–1 hydrochloric acid and 150 mg mL–1 NBS solution were added successively; the
flasks were let stand for 10 min under occasional shaking. Then, 1 mL of 40 mg mL–1
methylene blue solution was added to each flask, the volume was adjusted to the mark
with water and mixed. The absorbance of each solution was measured at 665 nm against
a reagent blank after 5 min.
In each spectrophotometric method, the concentration of the unknown was read from
the calibration graph or computed from the regression equation derived from Beer’s law
data.
The limits of detection (LOD) and quantification (LOQ) were calculated according
to the current ICH guidelines (23) using the following formulae:
LOD
SD
a
B
=
3.3
and LOQ
SD
a
B
=
10
where SDB is the standard deviation of seven reagent blank determinations and a is the
slope of the calibration curve.
Procedure for tablets
The following formulations containing SBS were purchased from local commercial
sources and used in the investigation: A, Asthalin tablets, (Cipla India Ltd.) each con-
taining 2/4 mg of SBS, B, Asmanil tablets, (Inga Pharmaceuticals, India) containing 2/4
mg of SBS per tablet, C. Bronkotab tablets, (GSK, India) containing 2/4 mg of SBS and D.
Salbu capsules (Upjohn Pharm., India) containing 4/8 mg of SBS per capsule.
Fifty to 100 tablets or the contents of 50 capsules were accurately weighed and pow-
dered. An amount of tablet/capsule powder equivalent to 100 mg of SBS was accurately
weighed into a 100-mL calibrated flask, 60-mL of water was added and shaken for 20
min. Then, the volume was diluted to the mark with water, the content was mixed well
and filtered using a Whatman No. 42 filter paper. The first 10-mL portion of the filtrate
was discarded and a convenient aliquot (e.g., 3 mL) of the subsequent portion was ana-
lyzed by titrimetry as described earlier. The filtrate (1 mg mL–1 in SBS) was diluted with
water to obtain 5 and 10 mg mL–1 concentrations and subjected to spectrophotometric
analysis as described above.
Recovery experiment. – To a fixed and known amount of drug in the tablet/capsule
powder (pre-analysed), pure SBS was added at three different levels, and the total was
found by the proposed methods, from which the percent recovery of pure drug added
was calculated.
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Selectivity testing
A separate selectivity test was performed by applying the proposed methods to the
determination of SBS in a synthetic mixture consisting of SBS (100 mg), talc (250 mg),
starch (300 mg), lactose (30 mg), calcium gluconate (50 mg), calcium dihydrogenortho-
phosphate (20 mg), sodium alginate (70 mg) and magnesium stearate (100 mg), in the ratio
of 1:2.5:3.0:0.3:0.5:0.2:0.7:1. SBS was extracted with three 20 mL portions of water and fil-
tered. The filtrate was washed with water; the filtrate and washings were collected in a
100-mL calibrated flask and diluted to volume with water and mixed well. A convenient
aliquot of the extract was subjected to analysis by titrimetry. The extract was suitably dilut-
ed to get 5 and 10 µg mL–1 solutions and was analyzed by spectrophotometric methods.
RESULTS AND DISCUSSION
The proposed methods are indirect and are based on the determination of surplus
NBS after allowing the reaction between SBS and NBS as oxidant to occur. In titrimetry,
the unreacted NBS is determined iodometrically, and in spectrophotometric methods, the
same is determined by reacting with a fixed amount of either rhodamine-B or methylene
blue. The latter methods make use of the bleaching action of NBS on either dye, the dis-
colouration being caused by the oxidative destruction of the dye.
Titrimetry
The reaction stoichiometry that was used for all calculations was found to be 1:6.
The relation between the amount of the drug and titration end point was examined. The
linearity is apparent from the calculated correlation coefficient of –0.9954 and suggests
that the reaction between SBS and NBS proceeds stoichiometrically in the ratio 1:6. Non-
stoichiometric results were obtained in a hydrochloric acid medium as well as sulphuric
acid medium. Quantitative results were obtained in an acetic acid medium and a 1.0 mol L–1
acetic acid concentration was found optimal although the reaction stoichiometry was un-
affected in the range 0.2–2.0 mol L–1 acetic acid. The oxidation reaction was found to be
complete and quantitative in 15 min and contact times up to 25 min had no effect on the
stoichiometry and the results. Beyond 25 min and up to 60 min, a small amount of NBS
was consumed but without producing any definite stoichiometry. Hence, it is necessary
to terminate the oxidation step at the end of the 15th min to obtain accurate and precise
results. A 10-mL aliquot of 0.01 mol L–1 NBS (0.1 mmol) solution was found adequate for
quantitative oxidation of SBS in the range determined 0.1–0.5 mg mL–1.
Spectrophotometry
In the spectrophotometric methods, SBS was added to a fixed and known amount
of NBS, and after the reaction was judged to be complete, residual NBS was determined
by reacting with a fixed amount of either rhodamine B or methylene blue. SBS, when
added in increasing amounts to a fixed amount of NBS, consumed the latter, and a con-
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comitant fall in NBS concentration occurred. When a fixed amount of either dye was re-
acted with decreasing amounts of NBS, a concomitant increase in the dye concentration
occurred. This was observed as a proportional increase in the absorbance at the respec-
tive lmax with increasing concentration of SBS, as shown by the correlation coefficients
of 0.9993 (method A) and 0.9988 (method B).
Preliminary experiments were conducted to determine the maximum concentrati-
ons of rhodamine B and methylene blue spectrophotometrically by measuring the absor-
bance of their acidic solutions at their respective lmax, and the upper limits were found
to be 5 and 4 mg mL–1 for rhodamine B and methylene blue, respectively. NBS concentra-
tion of 7 mg mL–1 was found to bleach the red colour due to 5 mg mL–1 rhodamine B,
whereas in the case of methylene blue 15 mg mL–1 NBS was sufficient to destroy the blue
colour of 4 mg mL–1 methylene blue. Hence, different amounts of SBS reacted with 7 mg
mL–1 NBS in method A and 15 mg mL–1 NBS in method B before determining the residu-
al NBS as described under the respective procedure.
Hydrochloric acid was found to be a convenient medium for the two steps involved
in both methods. For a quantitative reaction between SBS and NBS, a contact time of 10
min was found sufficient in both methods. Constant absorbance readings were obtained
when the reaction times were extended up to 20 min for method A and 30 min for met-
hod B and a standing time of 5–10 min was necessary for the bleaching of dye colour by
the residual NBS. The measured colour was stable for several hours even in the presence
of the reaction product.
Quantitation parameters
A linear correlation was found between absorbance at lmax and SBS concentration
and are described by the regression equations:
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Table I. Intra-day accuracy and precision of the methods
Method
SBS
takena
SBS
founda
er
(%)
RSD
(%)
CL
Titrimetry
0.15
0.30
0.45
0.15
0.30
0.45
0.7
0.3
0.2
1.4
0.1
0.8
0.15 ± 0.002
0.30 ± 0.00
0.45 ± 0.004
Spectrophotometric
method A
0.50
1.00
1.50
0.50
0.98
1.49
0.8
2.0
0.7
1.0
1.7
1.6
0.50 ± 0.005
0.98 ± 0.02
1.49 ± 0.02
Spectrophotometric
method B
1.50
3.00
4.50
1.51
2.95
4.48
0.5
1.7
0.4
1.8
1.8
2.4
1.51 ± 0.02
2.95 ± 0.05
4.48 ± 0.10
a In titrimetry, drug taken/found are in mg mL–1, and in spectrophotometric methods A and B
in µg mL–1.
er – relative error.
CL – confidence limits at 95% confidence level for six degrees of freedom.
A = –0.0014 + 0.4114 g; R = 0.9993, n = 7 (method A)
A = 0.0047 + 0.1187 g; R = 0.9998, n = 10 (method B)
where A is the absorbance and g is the concentration in mg mL–1, R is the correlation co-
efficient and n is the number of concentration levels. Beer’s law is obeyed for 0.25–1.75
and 0.5–5.0 mg mL–1 for method A and method B, respectively. The calculated apparent
molar absorptivity values were found to be 2.10 × 105 and 6.16 × 104 L mol–1 cm–1 for
method A and method B, respectively.
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Table II. Assay of formulations by the proposed methods
Formu-
lation
Nominal
amount
of SBS
(mg)
SBS found (%)a
Literature (9)
method
Proposed methods
Titrimetry
Spectrophoto-
metric method A
Spectrophoto-
metric method B
A 2
4
98.7 ± 0.9
99.1 ± 0.8
97.3 ± 1.3
t = 2.01
F = 2.09
100.9 ± 1.2
t = 2.84
F = 2.25
99.1 ± 1.0
t = 0.67
F = 1.19
98.0 ± 0.9
t = 2.04
F = 1.27
100.0 ± 1.2
t = 1.96
F = 1.78
101.2 ± 1.3
t = 3.16
F = 2.64
B 2
4
98.7 ± 1.1
97.8 ± 1.2
99.9 ± 1.0
t = 1.81
F = 1.21
98.7 ± 1.0
t = 1.29
F = 1.44
98.0 ± 1.0
t = 1.05
F = 1.21
99.1 ± 1.3
t = 1.64
F = 1.17
97.0 ± 1.3
t = 2.24
F = 1.40
100.1 ± 1.1
t = 3.16
F = 1.19
C 2
4
99.3 ± 0.9
100.7 ± 1.1
101.2 ± 1.1
t = 3.00
F = 1.49
99.1 ± 1.0
t = 2.41
F = 1.21
100.6 ± 1.1
t = 2.05
F = 1.49
98.6 ± 1.4
t = 2.65
F = 1.62
97.1 ± 1.0
t = 3.66
F = 1.23
102.05 ± 1.1
t = 1.94
F = 1.00
D 4
8
101.4 ± 0.7
100.3 ± 1.5
100.1 ± 1.1
t = 2.28
F = 2.47
98.9 ± 1.4
t = 1.53
F = 1.15
102.3 ± 1.3
t = 1.42
F = 3.45
99.3 ± 0.9
t = 1.32
F = 2.78
99.8 ± 1.3
t = 2.53
F = 3.45
101.8 ± 1.0
t = 1.90
F = 2.25
a Mean  SD, n = 5.
Precision and accuracy
Intra-day precision was assessed from the results of seven replicate analyses on pure
drug solution. The mean values and relative standard deviation (RSD) values for repli-
cate analyses at three different levels (amounts/concentrations) were calculated. To eva-
luate the inter-day precision, analysis was performed over a period of five days, prepar-
ing all solutions afresh each day.
The accuracy of the methods was determined by calculating the percentange devia-
tion observed in the analysis of pure drug solution and expressed as the relative error.
Table I summarizes the intra-day precision and accuracy data for the assay of SBS in pure
drug solution by the proposed methods and they were within 2.0%. The inter-day RSD
was £ 2.4%.
Application to dosage forms
The proposed methods were applied to the analysis of SBS in tablets and capsules
and the results were statistically compared with those obtained by the reported method
(9), which consisted of measuring the absorbance of blue chromogen at 670 nm after tre-
ating tablet extract with Folin-Ciocalteau reagent in alkaline medium. The calculated t-
and F-values were lower than the tabulated values at 95% confidence level, revealing
that the proposed methods and the reference method have similar accuracy and preci-
sion. In a few cases the t-calculated values are deviant and this can be ascribed to ran-
dom errors.
From the recovery experiment, it was found that the percent recovery of the pure
drug added to tablet/capsule powder ranged from 97.5 to 104.5, as shown in Table III,
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Table III. Recovery studya
Method
SBS in
formulation
SBS
added
Total SBS
found
SBS recovered
(%)b
Titrimetrya
0.15
0.15
0.15
0.10
0.20
0.30
0.24
0.34
0.45
97.5 ± 1.6
99.2 ± 2.1
101.1 ± 1.3
Spectrophotometric
method Aa
0.50
0.50
0.50
0.40
0.80
1.20
0.90
1.27
1.69
98.5 ± 2.6
96.6 ± 3.2
99.3 ± 2.7
Spectrophotometric
method Ba
2.00
2.00
2.00
1.00
2.00
3.00
3.02
4.09
4.94
102.1 ± 2.3
104.5 ± 4.1
97.9 ± 3.7
In titrimetry, SBS in formulation, added and total found, are in mg mL–1, and in spectrophotometric methods
A and B, in µg mL–1.
a Studied formulation tablet A, 2 mg SBS.
b Mean  SD, n = 3.
and that neither the end point detection in titrimetry nor absorbance measurement in
spectrophotometry was affected by tablet excipients such as talc, starch, lactose, magne-
sium stearate, sodium alginate, calcium gluconate and calcium dihydrogenorthophos-
phate.
The recovery of SBS in selectivity testing was found to be 103.5 ± 1.3, 102.8 ± 1.8 and
101.7 ± 1.3 for titrimetric, spectrophotometric method A and method B, respectively.
The proposed methods are simple, rapid and reliable compared to most existing
methods. In contrast to the direct titration method (16) reported earlier, the proposed
method is more sensitive with a determinable range of 0.1–0.5 mg mL–1 (1.73 × 10–4 –
8.68 × 10–4 mol L–1) and can be applied to a single tablet or capsule so that tablet to tab-
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Table IV. Comparison of reported spectrophotometric methods with the proposed method
for the assay of SBS
Reagent(s) used lmax (nm)
Beer’s law
limits
(mg mL–1)
Molar
absorptivity
(L mol–1 cm–1)
Remarks Reference
Folin-Ciocalteau re-
agent
760 0.0–6.0 – – 4
Folin-Ciocalteau re-
agent
750 1–15 – on-line solid phase
extraction and flow
injection
5
Iron(III)-1,10 –
phenanthroline
510 400–4000 – 6
Ferricyanide-4-
aminophenazone
505 25–175 – heating, waiting time
30 min
7
Cerium(IV)/MBTH 530 upto 15 2.4 ´ 104 extraction, expensive
reagent
8
NaNO2/PHSA 440 upto 10 – – 9
NaNO2/3-amino
pyridine
440 1–10 – – 10
NaNO2 410 5–60 – boiling, 30 min 11
KNO3/H2SO4 420 0–48 – boiling, 30 min 12
HNO3/H2SO4/
Meisenheimer complex
formation
386 4.8–16.0 – boiling, 20 min 13
DCQC 1–30 – organic solvent 14
TCNQ 2–20 – organic solvent 14
NBS/rhodamine B
NBS/methylene blue
555
665
0.125–1.75
0.5–5.0
2.10 ´ 105
6.16 ´ 104
this paper
this paper
MBTH – 3-methyl-benzothiazolin-2-one hydrazone
PHSA – phenylhydrazine sulphonic acid
DCQC – 2,6-dichloroquinone chlorimide
TCNQ – 7,7,8,8-tetracyanoquinodimethane
let or capsule to capsule variation, if desirable, can be followed. The methods are accu-
rate to –3.0 to +2.3% when applied to the determination of SBS in formulations and the
relative standard deviation varied from 0.9 to 1.4%. The selectivity as determined from
accuracy estimation (+1.7 to +3.5%) was good; in the recovery study via the standard ad-
dition method accuracy ranged from –2.5 to +4.5%. Even precisionwise, the selectivity
data show comparable RSDS to that of recovery experiments, 1.3–1.8 vs. 1.6–4.1%. The
performance characteristics of the existing spectrophotometric methods and the present
methods are given in Table IV, from which it is obviously clear that the proposed meth-
ods are free from drastic experimental conditions such as heating or extraction step un-
like many reported procedures. Both methods are highly sensitive compared to all the
existing spectrophotometric methods, as shown by the molar absorptivity values; and in
fact, the method using rhodamine B is the most sensitive one ever reported for salbutamol.
Further, both methods are based on the ultimate measurement of dye colour, which is
found to be exceptionally stable under the described experimental conditions, and the mea-
surement is made at longer wavelengths where the interference from the excipients is far
less compared to shorter wavelengths used in many reported procedures. The proposed
methods use eco-friendly and inexpensive chemicals and seldom employ organic solvents.
CONCLUSIONS
In conclusion, the results of the assay demonstrate that the proposed methods can
be used to determine the content uniformity of tablets and capsules, as well as the purity
of salbutamol raw material. Besides the simplicity of the procedures, the relative cheap-
ness of apparatus demonstrates their advantageous characteristics in addition to their
high accuracy and precision. The spectrophotometric methods described in the present
work have the clear advantages of sensitivity comparable to that achieved by an expen-
sive technique like HPLC. Applicability of spectrophotometric to the determination of
salbutamol in urine and blood samples, of course, after appropriate sample pretreat-
ment, will be the topic of our further research.
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S A @ E TA K
Brze titrimetrijske i spektrofometrijske metode za odre|ivanje
salbutamol sulfata koriste}i N-bromsukcinimid
KANAKAPURA BASAVAIAH, BANKAVADI CHIKKASWAMY SOMASHEKAR i VEERAIAH RAMAKRISHNA
U radu su opisane jedna titrimetrijska i dvije spektrofotometrijske metode za odre-
|ivanje salbutamol sulfata (SBS) ~iste tvari i u tabletama. Opisane metode su jednostavne,
osjetljive i brze, a kao reagense koriste N-bromsukcinimid (NBS) i dva bojila, rodamin-B
i metilensko modrilo. U titrimetrijskoj metodi, vodenoj otopini salbutamol sulfata do-
dana je otopina NBS-a u octenoj kiselini u suvi{ku, te je nakon potpune oksidacije SBS-a
jodometrijski odre|ena koli~ina neizreagiranog oksidansa. U spektrofotometrijskim me-
todama dodaje se poznati suvi{ak NBS-a u kiselom mediju nakon ~ega se neizreagirani
suvi{ak oksidansa odre|uje nakon reakcije s rodaminom-B mjere}i apsorbanciju na 555
nm (metoda A) ili metilenskim modrilom mjere}i apsorbanciju na 665 nm (metoda B). U
svim metodama, koli~ina NBS-a koji reagira ekvivalentna je sadr`aju SBS-a. Titrimetrij-
ska metoda je primjenjiva u rasponu koncentracija od 1,74 × 10–4 do 8,68 × 10–4 mol L–1.
SBS i NBS reagiraju u stehiometrijskom omjeru 1:6. U spektrofotometrijskim metodama
apsorbancija linearno raste s koncentracijom SBS-a, {to je potvr|eno koeficijentima ko-
relacije od 0,9993 za metodu A te 0,9988 za metodu B. Sustavi slijede Beer-ov zakon unu-
tar koncentracija 0,25–1,75 mg mL–1 (metoda A) i 0,5–5,0 mg mL–1 (metoda B). Izra~unate
vrijednosti molarnog apsorpcijskog koeficijenta iznose 2,10 × 105 za metodu A i 6,16 ×
104 L mol–1 cm–1 za metodu B. Granice detekcije i kvantifikacije, ispravnost i preciznost
(ponovljivost i intermedijarska preciznost) ponovljivost su za obje spektrofotometrijske
metode. Metode su uspje{no primijenjene za analizu SBS-a u tabletama i kapsulama, a
rezultati su statisti~ki uspore|eni s referentnom metodom. Uobi~ajene pomo}ne tvari u
tabletama nisu interferirale tijekom odre|ivanja. Ispravnost metoda potvr|ena je i me-
todom standardne adicije.
Klju~ne rije~i: salbutamol sulfat, analiza, titrimetrija, spektrofotometrija, N-bromsukcinimid
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